Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare Revenue Climbs 8 Percent in Q4 as Profit Surges 16 Percent

NEW YORK (GenomeWeb News) — General Electric today said that fourth-quarter revenue for its Healthcare division rose 8 percent as income swelled 16 percent.
 
GE Healthcare’s receipts for the three months ended Dec. 31, 2006, rose to $4.85 billion from $4.48 billion year over year.
 
GE Healthcare’s earnings for the quarter increased to $1.15 billion from $995 million in the fourth quarter of 2005.
 
GE did not break out its research and development expenses for the Healthcare segment.
 
GE's total revenues for the quarter were $44.6 billion, up from $40.3 billion during the same period last year.
 
Late yesterday afternoon, GE Healthcare said it plans to buy Abbott Technologies’ in vitro and point-of-care divisions for $8.13 billion in cash.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.